Indivior (LON:INDV) Stock Price Down 16% – Here’s Why

Indivior PLC (LON:INDV) shares traded down 16% on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 729.50 ($9.18). 78,684,203 shares changed hands during trading, an increase of 2,668% from the average session volume of 2,842,694 shares. The stock had previously closed at GBX 868 ($10.92).

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reiterated a “buy” rating and set a GBX 1,800 ($22.65) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Trading Down 15.7 %

The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The company has a market capitalization of £1.14 billion, a P/E ratio of -606.93, a PEG ratio of -5.57 and a beta of 0.19. The business has a 50 day moving average price of GBX 928.06 and a 200 day moving average price of GBX 853.71.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.